Gustavo Leite serves as a member of the Board of Directors at Gênica, where responsibilities include defining strategic guidelines and overseeing financial assessments. With extensive experience in leadership roles, Gustavo has been a member of the Scientific Committee at CTC since 2011, contributing to long-term planning for R&D and establishing technological directives. As CEO of CTC, significant market share growth was achieved through strategic redirection. Previous roles include CEO at Grupo Atalla, where financial savings were realized through debt renegotiation, and founder of Avanti Asset Management, which gained recognition for high returns in the financial sector. Further achievements include revitalizing operations at Hospital Albert Einstein and Monsanto, leading impactful biotechnological innovations. Gustavo holds multiple professional certificates from prestigious institutions and a Bachelor of Science in Mechanical Engineering from UERJ.